Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.61.1.37PMID 11779756PMCID PMC1753869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymyositis and dermatomyositis

  2002cited by this paper
• Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis.

  2000cited by this paper
• Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.

  2000cited by this paper
• Current approach to the treatment of polymyositis and dermatomyositis

  2000cited by this paper
• Interstitial lung disease in polymyositis and dermatomyositis

  2000cited by this paper
• [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].

  2000cited by this paper
• Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.

  1999cited by this paper
• IGIV in Neurology — Evidence and Recommendations

  1999cited by this paper
• Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines

  1999cited by this paper
• Immunoglobulin therapy in inflammatory myopathies

  1998cited by this paper
• Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?

  1997cited by this paper
• Long-term prognosis of 69 patients with dermatomyositis or polymyositis.

  1996cited by this paper
• [The efficacy of cyclosporin in the treatment of myositis].

  1995cited by this paper
• Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin.

  1995cited by this paper
• Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

  1994cited by this paper
• Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.

  1993cited by this paper
• The electrodiagnostic examination with myopathies.

  1993cited by this paper
• A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

  1993cited by this paper
• Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

  1992cited by this paper
• Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

  1991cited by this paper
• Cyclosporin A treatment of dermatomyositis.

  1991cited by this paper
• Neuroimmune Networks

  1990cited by this paper
• Cyclosporine treatment for intractable polymyositis.

  1987cited by this paper
• Cyclosporin for polymyositis.

  1986cited by this paper
• Severe dermatomyositis treated with cyclosporin A.

  1986cited by this paper
• Cyclosporin for polymyositis.

  1984cited by this paper
• Prednisone and azathioprine for polymyositis: long-term followup.

  1981cited by this paper
• Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients.

  1981cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Polymyositis and dermatomyositis (second of two parts).

  1975cited by this paper

• Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes

  2025cites this paper
• Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study

  2024cites this paper
• Pharmacological Strategies in Dermatomyositis: Current Treatments and Future Directions

  2024cites this paper
• Subcutaneous immunoglobulin for patients with idiopathic inflammatory myopathies: a real-world single centre experience.

  2023cites this paper
• Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use

  2023cites this paper
• Dermatomyositis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society

  2021cites this paper
• Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study.

  2021cites this paper
• Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.

  2021cites this paper
• Autoimmune myositis—Mechanism and therapy development

  2021cites this paper
• Therapieoptionen und outcome bei idiopathischen entzündlichen Muskelerkrankungen

  2021cites this paper
• Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis

  2020cites this paper
• Pulmonary Manifestations of Connective Tissue Diseases

  2020cites this paper
• Clinical trials and novel therapeutics in dermatomyositis

  2020cites this paper
• Intravenous Immunoglobulin for Inflammatory Myositis

  2020influential citation
• Intravenous Immunoglobulin Treatment in Rheumatic Diseases

  2019cites this paper
• Immunoglobulin Treatment in Neuromuscular Medicine.

  2019cites this paper
• Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists

  2018cites this paper
• Treatment of inflammatory myopathies

  2018cites this paper
• Autoimmune Myopathies: Updates on Evaluation and Treatment

  2018cites this paper
• Current Treatment for Myositis

  2018cites this paper
• The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies

  2017cites this paper
• The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy☆☆☆

  2017cites this paper
• Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies.

  2017cites this paper
• Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions

  2017cites this paper
• 10 Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2017cites this paper
• Idiopathic inflammatory myositis.

  2016cites this paper
• Chapter 26 – Juvenile Dermatomyositis

  2016cites this paper
• Dermatomyositis: A Rare Extra-intestinal Manifestation of Ulcerative Colitis

  2016cites this paper
• 150 – Management of inflammatory muscle disease

  2015cites this paper
• Cutaneous dermatomyositis in the era of biologicals

  2015cites this paper
• Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series

  2015cites this paper
• Update on the treatment of myositis

  2014cites this paper
• Prise en charge thérapeutique des polymyosites, dermatomyosites, myosites de chevauchement et myopathies nécrosantes auto-immunes

  2014cites this paper
• Pulmonary involvement in polymyositis and dermatomyositis

  2014cites this paper
• [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].

  2014cites this paper
• Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations

  2013cites this paper
• Therapeutic advances in myositis

  2012cites this paper
• Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review

  2012cites this paper
• Current management of dermatomyositis

  2012cites this paper
• Management of cutaneous dermatomyositis

  2012cites this paper
• Prevention Strategies for Type 1 Diabetes Mellitus

  2012cites this paper
• Idiopathic Inflammatory Myopathies

  2012cites this paper
• Intravenous Immunoglobulin in the Treatment of Neurological Diseases

  2011cites this paper
• Therapeutic Approaches in Myositis

  2011cites this paper
• Mechanisms of Action of Intravenous Immunoglobulin in Inflammatory Muscle Disease

  2011cites this paper
• Chapter 24 – JUVENILE DERMATOMYOSITIS

  2011cites this paper
• Therapy of polymyositis and dermatomyositis.

  2011cites this paper
• Idiopathic inflammatory myopathies.

  2011cites this paper
• Immunoglobulin Treatment in Polymyositis and Dermatomyositis

  2011cites this paper
• Therapie mit Immunglobulinen

  2010cites this paper
• The role of high-dose intravenous immunoglobulin in rheumatology.

  2010cites this paper
• [Intravenous IgG for treatment of neuromuscular diseases].

  2010cites this paper
• Chapter 14 – Targeted Treatment of the Idiopathic Inflammatory Myopathies

  2010cites this paper
• Idiopathic inflammatory myopathies

  2009cites this paper
• Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis

  2009cites this paper
• Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the aanem AD HOC committee

  2009cites this paper
• STUDIES ON INTERLEUKIN-1 IN IDIOPATHIC INFLAMMATORY MYOPATHIES

  2009cites this paper
• Idiopathic inflammatory myopathies.

  2009cites this paper
• Pulmonary involvement in polymyositis and dermatomyositis

  2009cites this paper
• Dermatomyositis: current and future treatments

  2009cites this paper
• 5. High Dose Intravenous Immunoglobulin

  2009cites this paper
• Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.

  2009cites this paper
• The treatment and prognosis of dermatomyositis: an updated review.

  2008cites this paper
• Using immunoglobulins in muscular disease treatment.

  2008cites this paper
• [Current therapy for polymyositis and dermatomyositis].

  2008cites this paper
• Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

  2008cites this paper
• EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

  2008cites this paper
• Using immunoglobulins in muscular disease treatment

  2008cites this paper
• Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies

  2007cites this paper
• The role of autoantibodies in inflammatory myopathies

  2007cites this paper
• Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features.

  2007cites this paper
• Guidelines on the use of intravenous immune globulin for neurologic conditions.

  2007cites this paper
• Clinical Characteristics of the Lung Involvement in Korean Patients with Inflammatory Myositis

  2007influential citation
• Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).

  2007cites this paper
• Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome

  2007cites this paper
• Studies of immunopathogenic mecha- nisms and treatment of chronic, inflam - matory myopathies, myositis

  2007cites this paper
• Miopatias inflamatórias idiopáticas

  2007cites this paper
• The use of i.v. IG therapy in dermatology

  2007cites this paper
• Dermatomiositis y sistema del complemento: Relación entre actividad de la enfermedad y grado de activación del complemento. Comparación con marcadores bioquímicos tradicionales

  2007cites this paper
• Inflammatory muscle disease: Clinical presentation and assessment of patients

  2007cites this paper
• Established and new treatments of the idiopathic inflammatory myopathies: dermatomyositis and polymyositis.

  2007cites this paper
• [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].

  2007cites this paper
• Treatment of inflammatory myopathies

  2006cites this paper
• Skeletal muscle disorders associated with inflammatory bowel diseases: occurrence of myositis in a patient with ulcerative colitis and Hashimoto's thyroiditis—case report and review of the literature

  2006cites this paper
• Off-label uses of biologic agents in dermatology: a 2006 update.

  2006cites this paper
• Disease-specifi c quality indicators , outcome measures and guidelines in polymyositis and dermatomyositis

  2006cites this paper
• National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis

  2006cites this paper
• [Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases].

  2006cites this paper
• Eficacia de tacrolimus (FK-506) en el tratamiento de las formas graves de dermatomiositis infantil: estudio de 6 casos

  2006cites this paper
• Treatment of inflammatory dermatoses by tumour necrosis factor antagonists

  2006cites this paper
• Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies

  2006cites this paper
• i.v.-Immunglobuline bei chronischen idiopathischen Myositiden

  2005cites this paper
• IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status

  2005cites this paper
• Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

  2005cites this paper
• Rituximab in the treatment of dermatomyositis: an open-label pilot study.

  2005cites this paper
• [Intravenous immunoglobulins in chronic idiopathic myositis].

  2005cites this paper
• International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.

  2005cites this paper
• The effects of combined creatine monohydrate supplementation and physical training on body composition and muscular function in patients with inflammatory myopathies

  2005cites this paper
• Pentaglobin in steroid-resistant severe acute respiratory syndrome.

  2004cites this paper
• Collagen vascular diseases.

  2004cites this paper